Prevest Denpro

509.00
-3.00
(-0.59%)
Market Cap
610.90 Cr
EPS
13.45
PE Ratio
34.55
Dividend Yield
0.20 %
Industry
Healthcare
52 Week High
686.00
52 Week Low
351.00
PB Ratio
6.41
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,534.60
#1 25,682.02
80.66
#1 1,434.50
24.59
#1 258
#1 31.08
68.06
370.40
1,970.76
67.06
307.90
-0.45
43
-46.46
55.07
509.00
#3 610.90
#3 34.55
#6 59.30
#2 30.58
#3 16
#2 25.00
55.57
241.00
241.00
-
102.40
-13.51
-2
-1,500.00
53.40
235.00
125.75
76.77
17.80
#1 136.23
2
-98.33
54.48
105.85
110.50
#1 11.28
109.90
-1.43
10
-
50.14
131.30
47.90
49.19
51.30
-2.84
1
-400.00
61.32
125.00
41.30
82.78
14.00
27.27
1
-
84.07
45.00
38.93
20.81
32.30
14.13
3
0.50
49.54
74.19
37.42
-
89.80
17.54
-3
-35.71
53.86
Growth Rate
Revenue Growth
30.58 %
Net Income Growth
35.80 %
Cash Flow Change
-81.73 %
ROE
6.49 %
ROCE
4.52 %
EBITDA Margin (Avg.)
-0.69 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
14
14
14
17
14
17
16
Expenses
8
9
9
10
9
11
10
EBITDA
6
5
5
7
5
7
6
Operating Profit %
37 %
33 %
33 %
37 %
34 %
36 %
35 %
Depreciation
0
0
0
1
1
1
1
Interest
0
0
0
0
0
0
0
Profit Before Tax
5
5
5
6
5
6
6
Tax
1
1
1
2
1
2
1
Net Profit
4
4
4
5
4
5
5
EPS in ₹
3.40
3.04
3.03
3.98
3.06
4.01
3.77

Balance Sheet

Balance Sheet
2024
Total Assets
95
Fixed Assets
27
Current Assets
68
Capital Work in Progress
0
Investments
2
Other Assets
66
Total Liabilities
95
Current Liabilities
6
Non Current Liabilities
1
Total Equity
89
Reserve & Surplus
77
Share Capital
12

Cash Flow

Cash Flow
2024
Net Cash Flow
10
Investing Activities
-2
Operating Activities
12
Financing Activities
-0

Share Holding

% Holding
Sept 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.31 %
0.00 %
0.52 %
1.11 %
0.63 %
0.63 %
0.63 %
DIIs
4.15 %
1.21 %
1.16 %
1.16 %
0.95 %
0.95 %
0.61 %
0.71 %
0.00 %
0.68 %
0.68 %
0.68 %
0.71 %
1.28 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.53 %
21.06 %
21.47 %
21.89 %
22.41 %
22.24 %
20.60 %
20.95 %
19.80 %
19.43 %
18.61 %
20.35 %
20.04 %
19.54 %
Others
13.72 %
4.12 %
3.77 %
3.34 %
3.04 %
3.20 %
5.19 %
4.42 %
6.60 %
5.76 %
5.99 %
4.73 %
5.01 %
4.95 %
No of Share Holders
7
1,003
1,256
1,496
1,544
1,613
1,758
1,937
2,040
1,991
1,896
1,822
1,832
1,887

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.23 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Closure of Trading WindowMar 27, 2025
Integrated Filing (Financial)Feb 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Investment In Axiodent Inc.Feb 01, 2025
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As On Period Ended December 31 2024)Feb 01, 2025
Outcome Of The Board Meeting Held Today I.E. February 01 2025Feb 01, 2025
Board Meeting Outcome for Board Meeting Held On Today I.E. February 01 2025Feb 01, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Saturday February 01 2025.Jan 27, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Closure of Trading WindowDec 28, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 22, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 21, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As On Period Ended September 30, 2024)Nov 12, 2024
Considered And Approved The Unaudited Financial Results (Stanadlone And Consolidated) Of The Company For The Quarter And Half Year Ended On September 30, 2024Nov 11, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E., November 11, 2024Nov 11, 2024
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Monday, November 11, 2024.Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 19, 2024
Closure of Trading WindowSep 30, 2024
Intimation Of Appointment Of Cost Auditor Of The CompanySep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 07, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 06, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2024
Notice Of The 25Th Annual General Meeting Of The Company To Be Held On Friday, September 06, 2024.Aug 13, 2024
Reg. 34 (1) Annual Report.Aug 13, 2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Quarter Ended On June 30, 2024Aug 08, 2024
Considered And Approved The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On June 30, 2024Aug 08, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E., August 08, 2024Aug 08, 2024
Board Meeting Intimation To Consider And Approve The Unaudited Standalone & Consolidated Financial Results For First Quarter Ended 30.06.2024 And To Recommend Dividend.Jul 31, 2024
Board Meeting Intimation for To Consider Unaudited Standalone & Consolidated Financial Results For First Quarter Ended 30.06.2023 And To Recommend Dividend.Jul 31, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 15, 2024
Clarification On Price MovementJul 06, 2024
Clarification sought from Prevest Denpro LtdJul 06, 2024
Closure of Trading WindowJun 29, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 03, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 01, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As On Period Ended March 31, 2024)May 28, 2024
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Audited Financial Results Of The Company For The Quarter And Financial Year Ended On March 31, 2024.May 28, 2024
Audited Financial Results Of The Company For The Quarter And Financial Year Ended On March 31, 2024.May 28, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 08, 2024
Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended March 31, 2024May 06, 2024
Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended March 31, 2024May 03, 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2024
Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024Apr 20, 2024
Compliance Certificate Issued Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024Apr 18, 2024

Technical Indicators

RSI(14)
Neutral
56.69
ATR(14)
Volatile
25.37
STOCH(9,6)
Neutral
64.50
STOCH RSI(14)
Neutral
20.67
MACD(12,26)
Bullish
1.43
ADX(14)
Weak Trend
14.43
UO(9)
Bearish
56.81
ROC(12)
Uptrend And Accelerating
6.00
WillR(14)
Neutral
-28.61